| Entry |
|
|---|
| Name |
Dextofisopam (USAN/INN) |
|---|
| Formula |
C22H26N2O4
|
|---|
| Exact mass |
382.1893
|
|---|
| Mol weight |
382.45
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
DG01914 Anxiolytics, benzodiazepine derivatives
|
|---|
| Efficacy |
Antianxiety, Antistress |
|---|
| Comment |
Benzodiazepine derivative
See Tofisopam [DR: D01254]
Treatment of irritable bowel syndrome, Crohn's disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01567 GABA-A receptor agonist
D03737 Dextofisopam
DG01914 Anxiolytics, benzodiazepine derivatives
D03737 Dextofisopam
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D03737 Dextofisopam (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 28
1 C2y C 23.6534 -14.9894
2 C8y C 22.8113 -13.8798
3 C8y C 23.1465 -12.5230
4 C1y C 24.4075 -11.9449
5 N2x N 25.0592 -15.0146
6 C2y C 25.6611 -12.5672
7 N2x N 25.9476 -13.9359
8 C8x C 22.1394 -11.5546
9 C8y C 20.7974 -11.9427
10 C8y C 20.4622 -13.2995
11 C8x C 21.4693 -14.2676
12 C1a C 26.7052 -11.6328
13 C8y C 23.0189 -16.2391
14 C8x C 21.6173 -16.2391
15 C1b C 24.4292 -10.5700
16 C1a C 25.6532 -9.8889
17 O2a O 19.7883 -10.9723
18 C1a C 18.4433 -11.3611
19 C1a C 18.1081 -12.7179
20 O2a O 19.1173 -13.6883
21 C8y C 20.9173 -17.4516
22 C8y C 21.6173 -18.6640
23 C8x C 23.0189 -18.6640
24 C8x C 23.7189 -17.4516
25 O2a O 19.5173 -17.4516
26 C1a C 18.8173 -18.6640
27 C1a C 19.5173 -19.8764
28 O2a O 20.9173 -19.8764
BOND 30
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 2
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 6 12 1
14 1 13 1
15 13 14 1
16 4 15 1 #Up
17 15 16 1
18 9 17 1
19 17 18 1
20 19 20 1
21 10 20 1
22 14 21 2
23 21 22 1
24 22 23 2
25 23 24 1
26 13 24 2
27 21 25 1
28 25 26 1
29 27 28 1
30 22 28 1
|
|---|
